GLP_1 RA Ultrasound Study

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Glucagon Like Peptide-1 (GLP-1Delayed Gastric EmptyingRisk of AspirationDiabetesMorbid Obesity
Interventions
DRUG

Glucagon-Like Peptide-1 receptor agonists

GLP-1 RAs: Glucagon like peptide-1 receptor agonists, this includes patients who are on Liraglutide, Semaglutide, Dulaglutide and Tirzepatide.Tirzepatide which is a combined GLP-1 RA/glucose-dependent insulinotropic polypeptide (GIP) agonist is included as a part of GLP-1 RAs.

DIAGNOSTIC_TEST

Point of Care Gastric Ultrasound

A gastric ultrasound following a standard NPO period to determine gastric contents and risk of aspiration during surgery.

Trial Locations (1)

45299

Cincinnati Children's Hospital, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER